Nishiyama H, Tanaka Y, Hamada M, Ozaki M, et al. Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance. BMC Cancer 2023;23:565.
PMID: 37340317